Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic to Patent Disease Genes in Deal With Life Technologies

Premium

GAITHERSBURG, Md.--Gene Logic said last week it would partner with a Rockville, Md., reagent company, Life Technologies, to fully sequence and file patents on 5 percent of the human genes that offer the “most promising gateways for new medicines against major diseases,” which have been identified using Gene Logic’s GeneExpress 200 database suite.

 

Gene Logic will market the gene sequences as the Clone-Express Library, which will be available to users of its databases. Life Technologies will sell full length clones of the genes through a “click-through facility” within the database.

Filed under